200 related articles for article (PubMed ID: 31343827)
21. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study.
Chakraborty R; Patra S; Banerjee S; Pande A; Khan A; Mandol PC; Ghosh D; De SK; Das SS; Nag R
Cardiovasc Revasc Med; 2016; 17(3):151-4. PubMed ID: 26905052
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Sim HW; Thong EH; Tan HC; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Loh JP
Cardiovasc Revasc Med; 2019 Sep; 20(9):739-743. PubMed ID: 30442536
[TBL] [Abstract][Full Text] [Related]
23. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
24. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
25. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.
Wiebe J; Möllmann H; Most A; Dörr O; Weipert K; Rixe J; Liebetrau C; Elsässer A; Achenbach S; Hamm C; Nef H
Clin Res Cardiol; 2014 Feb; 103(2):141-8. PubMed ID: 24136291
[TBL] [Abstract][Full Text] [Related]
26. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
27. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ
Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380
[TBL] [Abstract][Full Text] [Related]
28. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
[TBL] [Abstract][Full Text] [Related]
29. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.
de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P
J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279
[TBL] [Abstract][Full Text] [Related]
30. Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.
Gasior P; Cheng Y; Xia J; Conditt GB; McGregor JC; Virmani R; Granada JF; Kaluza GL
Cardiol J; 2020; 27(2):115-125. PubMed ID: 30155861
[TBL] [Abstract][Full Text] [Related]
31. Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.
Postma W; Fabris E; Van der Ent M; Hermanides R; Buszman P; Von Birgelen C C; Cook S; Wedel H; De Luca G; Delewi R; Zijlstra F; Kedhi E
Catheter Cardiovasc Interv; 2020 Mar; 95(4):706-710. PubMed ID: 31268629
[TBL] [Abstract][Full Text] [Related]
32. Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
Colleran R; Kufner S; Harada Y; Giacoppo D; Cassese S; Repp J; Wiebe J; Lohaus R; Lahmann A; Schneider S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
Catheter Cardiovasc Interv; 2017 Feb; 89(3):367-374. PubMed ID: 27377301
[TBL] [Abstract][Full Text] [Related]
33. First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.
Chieffo A; Khawaja SA; Latib A; Vesga B; Moncada M; Delgado JA; Fonseca J; Testa L; Esposito G; Ferrone M; Cortese B; Maehara A; Granada JF; Colombo A;
EuroIntervention; 2020 Jun; 16(2):e133-e140. PubMed ID: 32149709
[TBL] [Abstract][Full Text] [Related]
34. Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.
Ochijewicz D; Tomaniak M; Kołtowski L; Rdzanek A; Pietrasik A; Proniewska K; Partyka L; Dijsktra J; Huczek Z; Filipiak K; Opolski G; Kochman J
Int J Cardiol; 2020 Aug; 312():27-32. PubMed ID: 32315682
[TBL] [Abstract][Full Text] [Related]
35. First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.
Song L; Sun Z; Guan C; Yan H; Yu M; Cui J; Mu C; Qiu H; Tang Y; Zhao Y; Qiao S; Suryapranata H; Gao R; Xu B;
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():648-657. PubMed ID: 31909884
[TBL] [Abstract][Full Text] [Related]
36. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
[TBL] [Abstract][Full Text] [Related]
37. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
[TBL] [Abstract][Full Text] [Related]
38. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
Sabaté M; Windecker S; Iñiguez A; Okkels-Jensen L; Cequier A; Brugaletta S; Hofma SH; Räber L; Christiansen EH; Suttorp M; Pilgrim T; Anne van Es G; Sotomi Y; García-García HM; Onuma Y; Serruys PW
Eur Heart J; 2016 Jan; 37(3):229-40. PubMed ID: 26405232
[TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
[TBL] [Abstract][Full Text] [Related]
40. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study.
Zhang YJ; Iqbal J; Nakatani S; Bourantas CV; Campos CM; Ishibashi Y; Cho YK; Veldhof S; Wang J; Onuma Y; Garcia-Garcia HM; Dudek D; van Geuns RJ; Serruys PW;
JACC Cardiovasc Interv; 2014 Dec; 7(12):1361-9. PubMed ID: 25457053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
